Dimensional Fund Advisors LP Purchases 2,482,519 Shares of Avantor, Inc. $AVTR

Dimensional Fund Advisors LP grew its holdings in Avantor, Inc. (NYSE:AVTR) by 22.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,383,746 shares of the company’s stock after purchasing an additional 2,482,519 shares during the quarter. Dimensional Fund Advisors LP owned about 1.96% of Avantor worth $167,001,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Dodge & Cox lifted its position in shares of Avantor by 17.1% during the 2nd quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock worth $1,580,655,000 after purchasing an additional 17,170,761 shares during the last quarter. Vanguard Group Inc. grew its holdings in Avantor by 1.8% in the 3rd quarter. Vanguard Group Inc. now owns 65,988,977 shares of the company’s stock valued at $823,542,000 after buying an additional 1,135,279 shares during the last quarter. Greenhaven Associates Inc. bought a new position in Avantor in the 3rd quarter worth approximately $228,528,000. Invesco Ltd. increased its position in Avantor by 36.5% in the 2nd quarter. Invesco Ltd. now owns 15,933,860 shares of the company’s stock worth $214,470,000 after buying an additional 4,264,449 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Avantor by 13.4% during the second quarter. The Manufacturers Life Insurance Company now owns 15,914,573 shares of the company’s stock worth $214,210,000 after buying an additional 1,879,874 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Avantor Stock Down 0.4%

Shares of AVTR stock opened at $8.14 on Tuesday. Avantor, Inc. has a one year low of $7.82 and a one year high of $18.02. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.18. The stock has a fifty day moving average price of $10.64 and a 200 day moving average price of $11.81. The stock has a market cap of $5.55 billion, a P/E ratio of -10.43, a price-to-earnings-growth ratio of 3.21 and a beta of 0.97.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The company had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The business’s revenue was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on AVTR. TD Cowen reissued a “hold” rating on shares of Avantor in a research report on Thursday, February 12th. UBS Group reiterated a “neutral” rating and set a $10.50 target price on shares of Avantor in a research note on Thursday, February 12th. Stifel Nicolaus set a $10.00 price target on shares of Avantor in a report on Thursday, February 12th. Zacks Research lowered shares of Avantor from a “hold” rating to a “strong sell” rating in a research report on Friday, February 13th. Finally, Wells Fargo & Company cut their price objective on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $11.80.

Insider Transactions at Avantor

In other Avantor news, Director Gregory T. Lucier purchased 50,000 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was purchased at an average price of $9.16 per share, with a total value of $458,000.00. Following the completion of the transaction, the director directly owned 50,000 shares of the company’s stock, valued at approximately $458,000. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gregory L. Summe purchased 100,000 shares of the business’s stock in a transaction on Thursday, February 12th. The shares were acquired at an average price of $9.40 per share, with a total value of $940,000.00. Following the purchase, the director owned 400,000 shares of the company’s stock, valued at approximately $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 1.20% of the company’s stock.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.